Amarin Corp Plc (AMRN)

[rosemountbomber]

Thanks Capt. Good to see no upward movement for Generics and an ever so slight upward movement for Vascepa. Although the change will not move the needle unless it is a harbinger of things to come. Main thing is that we maintain the revenue (not a given as some posters have hoped that excessive discounting hasn't caused the revenue to crash) and that buys us time until we can get those protected markets up and running.

Another thought about those protected markets (mainly the EU).......The Lovaza type stuff is basically taboo or not covered in the EU as far as reimbursement. So the first thought I have is that V should be at least be able to get scripts there equivalent to the V scripts here plus the Lovaza scripts here. But I wonder if Generic Lovaza can be easily obtained in the EU and some patients may be able to use GL (no reimbursement) but simply pay out of pocket for the cheap generic?